Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03105843Phase 4Completed
Phase 4, randomised, open-label trial of Bronchitol in cough variant asthma (CVA) and chronic cough (3 arms). Primary endpoint: Mid expiratory flows. Started Mar 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03105843.